ENVOY MEDICAL, INC. Net Income (Loss) Available to Common Stockholders, Diluted
ENVOY MEDICAL, INC. (COCH) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$7.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-10
- ENVOY MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$7.27M.
- ENVOY MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was -$5.70M.
- ENVOY MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was -$7.74M.
- ENVOY MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was -$7.75M.
- ENVOY MEDICAL, INC. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$31.27M.
- ENVOY MEDICAL, INC. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$15.92M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.27M 10-Q · filed 2026-08-10 | -$12.97M 10-Q · filed 2026-08-10 | -$20.71M derived: sum of 3 quarters · filed 2026-08-10 | -$28.46M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | -$5.70M POS AM · filed 2026-06-12 | -$13.44M derived: sum of 2 quarters · filed 2026-06-12 | -$21.18M derived: sum of 3 quarters · filed 2026-06-12 | -$28.13M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | -$7.74M derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | -$15.48M derived: sum of 2 quarters · filed 2026-06-12 | -$22.43M derived: sum of 3 quarters · filed 2026-08-10 | -$28.66M POS AM · filed 2026-06-12 | ||
| 2025-09-30 | -$7.75M 10-Q · filed 2025-11-10 | -$14.69M derived: sum of 2 quarters · filed 2026-08-10 | -$20.93M 10-Q · filed 2025-11-10 | -$28.61M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | -$6.94M 10-Q · filed 2026-08-10 | -$13.18M 10-Q · filed 2026-08-10 | -$20.86M derived: sum of 3 quarters · filed 2026-08-10 | -$28.20M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | -$6.24M POS AM · filed 2026-06-12 | -$13.92M derived: sum of 2 quarters · filed 2026-06-12 | -$21.26M derived: sum of 3 quarters · filed 2026-06-12 | -$26.57M derived: sum of 4 quarters · filed 2026-06-12 | ||
| 2024-12-31 | -$7.69M derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | -$15.03M derived: sum of 2 quarters · filed 2026-06-12 | -$20.34M derived: sum of 3 quarters · filed 2026-06-12 | -$27.97M POS AM · filed 2026-06-12 | ||
| 2024-09-30 | -$7.34M 10-Q · filed 2025-11-10 | -$12.65M derived: sum of 2 quarters · filed 2025-11-10 | -$20.29M 10-Q · filed 2025-11-10 | -$26.53M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | -$5.31M 10-Q · filed 2025-07-31 | -$12.95M 10-Q · filed 2025-07-31 | -$19.19M derived: sum of 3 quarters · filed 2025-07-31 | -$17.79M derived: sum of 4 quarters · filed 2025-07-31 | ||
| 2024-03-31 | -$7.63M 10-Q · filed 2025-05-01 | -$6.27M 10-Q · filed 2024-05-15 | -$13.88M derived: sum of 2 quarters · filed 2025-05-01 | -$12.47M derived: sum of 3 quarters · filed 2025-05-01 | -$25.72M derived: sum of 4 quarters · filed 2025-05-01 | |
| 2023-12-31 | -$6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$4.84M derived: sum of 2 quarters · filed 2025-03-31 | -$18.09M derived: sum of 3 quarters · filed 2025-03-31 | -$31.27M 10-K · filed 2025-03-31 | -$29.91M 10-K · filed 2024-04-01 | |
| 2023-09-30 | $1.40M 10-Q · filed 2024-11-14 | -$11.84M derived: sum of 2 quarters · filed 2024-11-14 | -$25.03M 10-Q · filed 2024-11-14 | -$36.57M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$13.25M 10-Q · filed 2024-08-12 | -$26.50M 10-Q · filed 2024-08-12 | -$37.98M derived: sum of 3 quarters · filed 2024-08-12 | -$39.31M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | -$13.25M 10-Q · filed 2024-05-15 | -$24.73M derived: sum of 2 quarters · filed 2024-05-15 | -$26.07M derived: sum of 3 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$11.48M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-01 | -$12.82M derived: sum of 2 quarters · filed 2024-04-01 | -$15.92M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$1.34M 10-Q/A · filed 2024-01-17 | -$4.45M 10-Q/A · filed 2024-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |